Genzada Pharmaceuticals in Sterling, Kansas has FDA approval to begin human clinical trials for a new cancer treatment. The drug is derived from a flower native to the Middle East that the company is growing in Kansas.
Genzada Pharmaceuticals in Sterling, Kansas has FDA approval to begin human clinical trials for a new cancer treatment. The drug is derived from a flower native to the Middle East that the company is growing in Kansas. Video screengrab/KSN
Genzada Pharmaceuticals in Sterling, Kansas has FDA approval to begin human clinical trials for a new cancer treatment. The drug is derived from a flower native to the Middle East that the company is growing in Kansas. Video screengrab/KSN